-
1
-
-
79952232216
-
Global cancer statistics
-
2-s2.0-79952232216 10.3322/caac.20107
-
Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA: A Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216 10.3322/caac.20107
-
(2011)
CA: A Cancer Journal for Clinicians
, vol.61
, Issue.2
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
2
-
-
63249118690
-
Screening and prostate-cancer mortality in a randomized european study
-
2-s2.0-63249118690 10.1056/NEJMoa0810084
-
Schroder F. H., Hugosson J., Roobol M. J., Tammela T. L. J., Ciatto S., Nelen V., Kwiatkowski M., Lujan M., Lilja H., Zappa M., Denis L. J., Recker F., Määpttänen A. B., Bangma C. H., Aus G., Villers A., Rebillard X., van Kwast T. D., Blijenberg B. G., Moss S. M., de Koning H. J., Auvinen A., Screening and prostate-cancer mortality in a randomized european study. The New England Journal of Medicine 2009 360 13 1320 1328 2-s2.0-63249118690 10.1056/NEJMoa0810084
-
(2009)
The New England Journal of Medicine
, vol.360
, Issue.13
, pp. 1320-1328
-
-
Schroder, F.H.1
Hugosson, J.2
Roobol, M.J.3
Tammela, T.L.J.4
Ciatto, S.5
Nelen, V.6
Kwiatkowski, M.7
Lujan, M.8
Lilja, H.9
Zappa, M.10
Denis, L.J.11
Recker, F.12
Määpttänen, A.B.13
Bangma, C.H.14
Aus, G.15
Villers, A.16
Rebillard, X.17
Van Kwast, T.D.18
Blijenberg, B.G.19
Moss, S.M.20
De Koning, H.J.21
Auvinen, A.22
more..
-
3
-
-
37049023209
-
Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer
-
DOI 10.1016/j.ijrobp.2007.06.054, PII S036030160701173X
-
Kuban D. A., Tucker S. L., Dong L., Starkschall G., Huang E. H., Cheung M. R., Lee A. K., Pollack A., Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. International Journal of Radiation, Oncology, Biology Physics 2008 70 1 67 74 2-s2.0-37049023209 10.1016/j.ijrobp.2007.06.054 (Pubitemid 350251041)
-
(2008)
International Journal of Radiation Oncology Biology Physics
, vol.70
, Issue.1
, pp. 67-74
-
-
Kuban, D.A.1
Tucker, S.L.2
Dong, L.3
Starkschall, G.4
Huang, E.H.5
Cheung, M.R.6
Lee, A.K.7
Pollack, A.8
-
4
-
-
77949509341
-
Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group/American College of Radiology 95-09
-
2-s2.0-77949509341 10.1200/JCO.2009.25.8475
-
Zietman A. L., Bae K., Slater J. D., Shipley W. U., Efstathiou J. A., Coen J. J., Bush D. A., Lunt M., Spiegel D. Y., Skowronski R., Jabola B. R., Rossi C. J., Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from Proton Radiation Oncology Group/American College Of Radiology 95-09. Journal of Clinical Oncology 2010 28 7 1106 1111 2-s2.0-77949509341 10.1200/JCO.2009.25.8475
-
(2010)
Journal of Clinical Oncology
, vol.28
, Issue.7
, pp. 1106-1111
-
-
Zietman, A.L.1
Bae, K.2
Slater, J.D.3
Shipley, W.U.4
Efstathiou, J.A.5
Coen, J.J.6
Bush, D.A.7
Lunt, M.8
Spiegel, D.Y.9
Skowronski, R.10
Jabola, B.R.11
Rossi, C.J.12
-
5
-
-
0021879466
-
Biologic basis for altered fractionation schemes
-
Withers H. R., Biologic basis for altered fractionation schemes. Cancer 1985 55 supplement 9 2086 2095 2-s2.0-0021879466 (Pubitemid 15077682)
-
(1985)
Cancer
, vol.55
, Issue.9 SUPPL.
, pp. 2086-2095
-
-
Withers, H.R.1
-
6
-
-
0020064973
-
Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships
-
Thames H. D. Jr., Withers H. R., Peters L. J., Fletcher G. H., Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. International Journal of Radiation, Oncology, Biology Physics 1982 8 2 219 226 2-s2.0-0020064973 (Pubitemid 12139897)
-
(1982)
International Journal of Radiation Oncology Biology Physics
, vol.8
, Issue.2
, pp. 219-226
-
-
Thames Jr., H.D.1
Withers, H.R.2
Peters, L.J.3
Fletcher, G.H.4
-
7
-
-
0024358259
-
The linear-quadratic formula and progress in fractionated radiotherapy
-
Fowler J. F., The linear-quadratic formula and progress in fractionated radiotherapy. British Journal of Radiology 1989 62 740 679 694 2-s2.0-0024358259 (Pubitemid 19194494)
-
(1989)
British Journal of Radiology
, vol.62
, Issue.740
, pp. 679-694
-
-
Fowler, J.F.1
-
8
-
-
79955722555
-
Isoeffect calculations with the linear quadratic and its extensions: An examination of model-dependent estimates at doses relevant to hypofractionation
-
2-s2.0-79955722555 10.4103/0971-6203.79689
-
McKenna F., Ahmad S., Isoeffect calculations with the linear quadratic and its extensions: an examination of model-dependent estimates at doses relevant to hypofractionation. Journal of Medical Physics 2011 36 2 100 106 2-s2.0-79955722555 10.4103/0971-6203.79689
-
(2011)
Journal of Medical Physics
, vol.36
, Issue.2
, pp. 100-106
-
-
McKenna, F.1
Ahmad, S.2
-
9
-
-
80052786190
-
Estimation of α / β for late rectal toxicity based on RTOG 94-06
-
2-s2.0-80052786190 10.1016/j.ijrobp.2010.11.080
-
Tucker S. L., Thames H. D., Michalski J. M., Bosch W. R., Mohan R., Winter K., Cox J. D., Purdy J. A., Dong L., Estimation of α / β for late rectal toxicity based on RTOG 94-06. International Journal of Radiation, Oncology, Biology Physics 2011 81 2 600 605 2-s2.0-80052786190 10.1016/j.ijrobp.2010.11.080
-
(2011)
International Journal of Radiation, Oncology, Biology Physics
, vol.81
, Issue.2
, pp. 600-605
-
-
Tucker, S.L.1
Thames, H.D.2
Michalski, J.M.3
Bosch, W.R.4
Mohan, R.5
Winter, K.6
Cox, J.D.7
Purdy, J.A.8
Dong, L.9
-
10
-
-
0032913909
-
Fractionation and protraction for radiotherapy of prostate carcinoma
-
DOI 10.1016/S0360-3016(98)00438-6, PII S0360301698004386
-
Brenner D. J., Hall E. J., Fractionation and protraction for radiotherapy of prostate carcinoma. International Journal of Radiation, Oncology, Biology Physics 1999 43 5 1095 1101 2-s2.0-0032913909 10.1016/S0360-3016(98)00438-6 (Pubitemid 29144800)
-
(1999)
International Journal of Radiation Oncology Biology Physics
, vol.43
, Issue.5
, pp. 1095-1101
-
-
Brenner, D.J.1
Hall, E.J.2
-
11
-
-
5744247185
-
Comparison of in vitro and in vivo α/β ratios for prostate cancer
-
DOI 10.1088/0031-9155/49/19/003, PII S0031915504827076
-
Carlson D. J., Stewart R. D., Li X. A., Jennings K., Wang J. Z., Guerrero M., Comparison of in vitro and in vivo α / β ratios for prostate cancer. Physics in Medicine and Biology 2004 49 19 4477 4491 2-s2.0-5744247185 10.1088/0031-9155/49/19/003 (Pubitemid 39378241)
-
(2004)
Physics in Medicine and Biology
, vol.49
, Issue.19
, pp. 4477-4491
-
-
Carlson, D.J.1
Stewart, R.D.2
Li, X.A.3
Jennings, K.4
Wang, J.Z.5
Guerrero, M.6
-
12
-
-
49749121119
-
The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery
-
2-s2.0-49749121119 10.1016/j.semradonc.2008.04.005
-
Kirkpatrick J. P., Meyer J. J., Marks L. B., The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Seminars in Radiation Oncology 2008 18 4 240 243 2-s2.0-49749121119 10.1016/j.semradonc.2008.04.005
-
(2008)
Seminars in Radiation Oncology
, vol.18
, Issue.4
, pp. 240-243
-
-
Kirkpatrick, J.P.1
Meyer, J.J.2
Marks, L.B.3
-
13
-
-
84891839772
-
The tumor radiobiology of SRS and SBRT: Are more than the 5 Rs involved ?
-
10.1016/j.ijrobp.2013.07.022
-
Brown J. M., Carlson D. J., Brenner D. J., The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved ? International Journal of Radiation, Oncology, Biology Physics 2014 88 2 254 262 10.1016/j.ijrobp.2013.07.022
-
(2014)
International Journal of Radiation, Oncology, Biology Physics
, vol.88
, Issue.2
, pp. 254-262
-
-
Brown, J.M.1
Carlson, D.J.2
Brenner, D.J.3
-
14
-
-
0001086274
-
The four R's of radiotherapy
-
New York, NY, USA Academic Press
-
Withers H. R., Lett J. T., Adler H., The four R's of radiotherapy. Advances in Radiation Biology 1975 5 New York, NY, USA Academic Press 241 271
-
(1975)
Advances in Radiation Biology
, vol.5
, pp. 241-271
-
-
Withers, H.R.1
Lett, J.T.2
Adler, H.3
-
15
-
-
0015622754
-
Changes in the rate of repopulation during multifraction irradiation of mouse skin
-
2-s2.0-0015622754
-
Denekamp J., Changes in the rate of repopulation during multifraction irradiation of mouse skin. British Journal of Radiology 1973 46 545 381 387 2-s2.0-0015622754
-
(1973)
British Journal of Radiology
, vol.46
, Issue.545
, pp. 381-387
-
-
Denekamp, J.1
-
16
-
-
0021645799
-
Fractionated radiation therappy after Strandqvist
-
Fowler J. F., Fractionated radiation therappy after Strandqvist. Acta Radiologica Oncology 1984 23 4 209 216 2-s2.0-0021645799 (Pubitemid 15072793)
-
(1984)
Acta Radiologica Oncology
, vol.23
, Issue.4
, pp. 209-216
-
-
Fowler, J.F.1
-
17
-
-
0025838346
-
Clinical evidence for tumor clonogen regeneration: Interpretations of the data
-
2-s2.0-0025838346 10.1016/0167-8140(91)90019-D
-
Bentzen S. M., Thames H. D., Clinical evidence for tumor clonogen regeneration: interpretations of the data. Radiotherapy & Oncology 1991 22 3 161 166 2-s2.0-0025838346 10.1016/0167-8140(91)90019-D
-
(1991)
Radiotherapy & Oncology
, vol.22
, Issue.3
, pp. 161-166
-
-
Bentzen, S.M.1
Thames, H.D.2
-
18
-
-
0023894783
-
The hazard of accelerated tumor clonogen repopulation during radiotherapy
-
2-s2.0-0023894783
-
Whithers H. R., Taylor J. M., Maciejewski B., The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncologica 1988 27 2 131 146 2-s2.0-0023894783
-
(1988)
Acta Oncologica
, vol.27
, Issue.2
, pp. 131-146
-
-
Whithers, H.R.1
Taylor, J.M.2
Maciejewski, B.3
-
19
-
-
0022629891
-
Cell kinetics and radiation biology
-
Denekamp J., Cell kinetics and radiation biology. International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine 1986 49 2 357 380 10.1080/09553008514552591 (Pubitemid 16182969)
-
(1986)
International Journal of Radiation Biology
, vol.49
, Issue.2
, pp. 357-380
-
-
Denekamp, J.1
-
20
-
-
0004630715
-
Normal tissue radioresistance in clinical radiotherapy
-
New York, NY, USA Masson
-
Withers H. R., Thames H. D., Peters L. J., Fletcher G. H., Nervi C., Withers H. R., Normal tissue radioresistance in clinical radiotherapy. Biological Bases and Clinical Implications of Tumor Radioresistance 1983 New York, NY, USA Masson
-
(1983)
Biological Bases and Clinical Implications of Tumor Radioresistance
-
-
Withers, H.R.1
Thames, H.D.2
Peters, L.J.3
Fletcher, G.H.4
Nervi, C.5
Withers, H.R.6
-
21
-
-
0020064973
-
Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships
-
Thames H. D. Jr., Withers H. R., Peters L. J., Fletcher G. H., Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. International Journal of Radiation, Oncology, Biology Physics 1982 8 2 219 226 2-s2.0-0020064973 (Pubitemid 12139897)
-
(1982)
International Journal of Radiation Oncology Biology Physics
, vol.8
, Issue.2
, pp. 219-226
-
-
Thames Jr., H.D.1
Withers, H.R.2
Peters, L.J.3
Fletcher, G.H.4
-
22
-
-
49749100424
-
Clinical experience using hypofractionated radiation schedules in breast cancer
-
2-s2.0-49749100424 10.1016/j.semradonc.2008.04.008
-
Whelan T. J., Kim D. H., Sussman J., Clinical experience using hypofractionated radiation schedules in breast cancer. Seminars in Radiation Oncology 2008 18 4 257 264 2-s2.0-49749100424 10.1016/j.semradonc.2008.04.008
-
(2008)
Seminars in Radiation Oncology
, vol.18
, Issue.4
, pp. 257-264
-
-
Whelan, T.J.1
Kim, D.H.2
Sussman, J.3
-
23
-
-
33646862836
-
Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial
-
DOI 10.1016/S1470-2045(06)70699-4, PII S1470204506706994
-
Owen J. R., Ashton A., Bliss J. M., Homewood J., Harper C., Hanson J., Haviland J., Bentzen S. M., Yarnold J. R., Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. The Lancet Oncology 2006 7 6 467 471 2-s2.0-33646862836 10.1016/S1470-2045(06)70699-4 (Pubitemid 43779171)
-
(2006)
Lancet Oncology
, vol.7
, Issue.6
, pp. 467-471
-
-
Owen, J.R.1
Ashton, A.2
Bliss, J.M.3
Homewood, J.4
Harper, C.5
Hanson, J.6
Haviland, J.7
Bentzen, S.M.8
Yarnold, J.R.9
-
24
-
-
0035879455
-
Is α/β for prostate tumors really low?
-
DOI 10.1016/S0360-3016(01)01607-8, PII S0360301601016078
-
Fowler J. F., Chappell R., Ritter M., Is α / β for prostate tumors really low? International Journal of Radiation, Oncology, Biology Physics 2001 50 4 1021 1031 2-s2.0-0035879455 10.1016/S0360-3016(01)01607-8 (Pubitemid 32594841)
-
(2001)
International Journal of Radiation Oncology Biology Physics
, vol.50
, Issue.4
, pp. 1021-1031
-
-
Fowler, J.1
Chappell, R.2
Ritter, M.3
-
25
-
-
83955161787
-
Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α / β = 1.4 (0.9-2.2) Gy
-
2-s2.0-83955161787 10.1016/j.ijrobp.2010.10.075
-
Miralbell R., Roberts S. A., Zubizarreta E., Hendry J. H., Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α / β = 1.4 (0.9-2.2) Gy. International Journal of Radiation Oncology Biology Physics 2012 82 1 e17 e24 2-s2.0-83955161787 10.1016/j.ijrobp.2010.10. 075
-
(2012)
International Journal of Radiation Oncology Biology Physics
, vol.82
, Issue.1
-
-
Miralbell, R.1
Roberts, S.A.2
Zubizarreta, E.3
Hendry, J.H.4
-
26
-
-
0037215315
-
How low is the α/β ratio for prostate cancer?
-
DOI 10.1016/S0360-3016(02)03828-2, PII S0360301602038282
-
Wang J. Z., Guerrero M., Li X. A., How low is the α / β ratio for prostate cancer? International Journal of Radiation Oncology Biology Physics 2003 55 1 194 203 10.1016/S0360-3016(02)03828-2 (Pubitemid 36020360)
-
(2003)
International Journal of Radiation Oncology Biology Physics
, vol.55
, Issue.1
, pp. 194-203
-
-
Wang, J.Z.1
Guerrero, M.2
Li, X.A.3
-
27
-
-
0142186650
-
How low is the α/β ratio for prostate cancer?
-
DOI 10.1016/S0360-3016(03)01455-X
-
Kal H., van Gellekom M. P., How low is the α / β ratio for prostate cancer? International Journal of Radiation, Oncology, Biology Physics 2003 57 4 1116 1121 2-s2.0-0142186650 10.1016/S0360-3016(03)01455-X (Pubitemid 37324131)
-
(2003)
International Journal of Radiation Oncology Biology Physics
, vol.57
, Issue.4
, pp. 1116-1121
-
-
Kal, H.B.1
Van Gellekom, M.P.R.2
-
28
-
-
0034183792
-
Is the prostate α/β ratio of 1.5 from Brenner and Hall a modeling artifact? [2]
-
DOI 10.1016/S0360-3016(00)00442-9, PII S0360301600004429
-
King C. R., Mayo C. S., Is the prostate α / β ratio of 1.5 from Brenner and Hall a modeling artifact? International Journal of Radiation, Oncology, Biology Physics 2000 47 2 536 539 2-s2.0-0034183792 10.1016/S0360-3016(00)00442-9 (Pubitemid 30236399)
-
(2000)
International Journal of Radiation Oncology Biology Physics
, vol.47
, Issue.2
, pp. 536-539
-
-
King, C.R.1
Mayo, C.S.2
-
29
-
-
84875276506
-
Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer
-
10.1016/j.ijrobp.2012.11.033
-
Pedicini P., Strigari L., Benassi M., Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer. International Journal of Radiation, Oncology, Biology Physics 2013 85 5 e231 e237 10.1016/j.ijrobp.2012.11.033
-
(2013)
International Journal of Radiation, Oncology, Biology Physics
, vol.85
, Issue.5
-
-
Pedicini, P.1
Strigari, L.2
Benassi, M.3
-
30
-
-
84881557290
-
Systematic review of hypofractionated radiation therapy for prostate cancer
-
10.1016/j.ctrv.2013.01.008
-
Zaorsky N. G., Ohri N., Showalter T. N., Dicker A. P., Den R. B., Systematic review of hypofractionated radiation therapy for prostate cancer. Cancer Treatment Reviews 2013 39 7 728 736 10.1016/j.ctrv.2013.01.008
-
(2013)
Cancer Treatment Reviews
, vol.39
, Issue.7
, pp. 728-736
-
-
Zaorsky, N.G.1
Ohri, N.2
Showalter, T.N.3
Dicker, A.P.4
Den, R.B.5
-
31
-
-
0025313292
-
Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984)
-
DOI 10.1016/0090-4295(90)80207-4
-
Lloyd-Davies R. W., Collins C. D., Swan A. V., Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984). Urology 1990 36 2 107 111 2-s2.0-0025313292 10.1016/0090-4295(90)80207-4 (Pubitemid 20239018)
-
(1990)
Urology
, vol.36
, Issue.2
, pp. 107-111
-
-
Lloyd-Davies, R.W.1
Collins, C.D.2
Swan, A.V.3
-
32
-
-
0026165938
-
Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique
-
2-s2.0-0026165938
-
Collins C. D., Lloyd-Davies R. W., Swan A. V., Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique. Clinical Oncology 1991 3 3 127 132 2-s2.0-0026165938
-
(1991)
Clinical Oncology
, vol.3
, Issue.3
, pp. 127-132
-
-
Collins, C.D.1
Lloyd-Davies, R.W.2
Swan, A.V.3
-
33
-
-
24944526722
-
Randomized trial comparing two fractionation schedules for patients with localized prostate cancer
-
2-s2.0-24944526722 10.1200/JCO.2005.06.153
-
Lukka H., Hayter C., Julian J. A., Warde P., Morris W. J., Gospodarowicz M., Levine M., Sathya J., Choo R., Prichard H., Brundage M., Kwan W., Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. Journal of Clinical Oncology 2005 23 25 6132 6138 2-s2.0-24944526722 10.1200/JCO.2005.06.153
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.25
, pp. 6132-6138
-
-
Lukka, H.1
Hayter, C.2
Julian, J.A.3
Warde, P.4
Morris, W.J.5
Gospodarowicz, M.6
Levine, M.7
Sathya, J.8
Choo, R.9
Prichard, H.10
Brundage, M.11
Kwan, W.12
-
34
-
-
33750297651
-
Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: Updated results of a phase III randomized trial
-
DOI 10.1016/j.ijrobp.2006.06.005, PII S0360301606009813
-
Yeoh E. E., Holloway R. H., Fraser R. J., Botten R. J., di Matteo A. C., Butters J., Weerasinghe S., Abeysinghe P., Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial. International Journal of Radiation, Oncology, Biology Physics 2006 66 4 1072 1083 2-s2.0-33750297651 10.1016/j.ijrobp.2006.06.005 (Pubitemid 44633501)
-
(2006)
International Journal of Radiation Oncology Biology Physics
, vol.66
, Issue.4
, pp. 1072-1083
-
-
Yeoh, E.E.1
Holloway, R.H.2
Fraser, R.J.3
Botten, R.J.4
Di Matteo, A.C.5
Butters, J.6
Weerasinghe, S.7
Abeysinghe, P.8
-
35
-
-
81855185482
-
Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: Final results of phase III randomized trial
-
2-s2.0-81855185482 10.1016/j.ijrobp.2010.07.1984
-
Yeoh E. E., Botten R. J., Butters J., di Matteo A. C., Holloway R. H., Fowler J., Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial. International Journal of Radiation Oncology Biology Physics 2011 81 5 1271 1278 2-s2.0-81855185482 10.1016/j.ijrobp.2010.07.1984
-
(2011)
International Journal of Radiation Oncology Biology Physics
, vol.81
, Issue.5
, pp. 1271-1278
-
-
Yeoh, E.E.1
Botten, R.J.2
Butters, J.3
Di Matteo, A.C.4
Holloway, R.H.5
Fowler, J.6
-
36
-
-
0030906817
-
Consensus statement: Guidelines for PSA following radiation therapy
-
DOI 10.1016/S0360-3016(97)00002-3, PII S0360301697000023
-
American Society for Therapeutic Radiology and Oncology Consensus Panel, Consensus statement: guidelines for PSA following radiation therapy. International Journal of Radiation Oncology Biology Physics 1997 37 5 1035 1041 2-s2.0-0030906817 10.1016/S0360-3016(97)00002-3 (Pubitemid 27230027)
-
(1997)
International Journal of Radiation Oncology Biology Physics
, vol.37
, Issue.5
, pp. 1035-1041
-
-
Cox, J.D.1
Grignon, D.J.2
Kaplan, R.S.3
Parsons, J.T.4
Schellhammer, P.F.5
-
37
-
-
37449026934
-
The phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer
-
2-s2.0-37449026934 10.1002/cncr.23139
-
Abramowitz M. C., Li T., Buyyounouski M. K., Ross E., Uzzo R. G., Pollack A., Horwitz E. M., The phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer 2008 112 1 55 60 2-s2.0-37449026934 10.1002/cncr.23139
-
(2008)
Cancer
, vol.112
, Issue.1
, pp. 55-60
-
-
Abramowitz, M.C.1
Li, T.2
Buyyounouski, M.K.3
Ross, E.4
Uzzo, R.G.5
Pollack, A.6
Horwitz, E.M.7
-
38
-
-
20144373530
-
Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
-
DOI 10.1038/sj.bjc.6602301
-
Dearnaley D. P., Hall E., Lawrence D., Huddart R. A., Eeles R., Nutting C. M., Gadd J., Warrington A., Bidmead M., Horwich A., Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. British Journal of Cancer 2005 92 3 488 498 2-s2.0-20144373530 10.1038/sj.bjc.6602301 (Pubitemid 40395529)
-
(2005)
British Journal of Cancer
, vol.92
, Issue.3
, pp. 488-498
-
-
Dearnaley, D.P.1
Hall, E.2
Lawrence, D.3
Huddart, R.A.4
Eeles, R.5
Nutting, C.M.6
Gadd, J.7
Warrington, A.8
Bidmead, M.9
Horwich, A.10
-
39
-
-
34047159109
-
The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: Results from the MRC RT01 trial (ISRCTN47772397)
-
DOI 10.1016/j.radonc.2007.02.014, PII S0167814007000837
-
Dearnaley D. P., Sydes M. R., Langley R. E., Graham J. D., Huddart R. A., Syndikus I., Matthews J. H. L., Scrase C. D., Jose C. C., Logue J., Stephens R. J., The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397). Radiotherapy & Oncology 2007 83 1 31 41 2-s2.0-34047159109 10.1016/j.radonc.2007.02.014 (Pubitemid 46527948)
-
(2007)
Radiotherapy and Oncology
, vol.83
, Issue.1
, pp. 31-41
-
-
Dearnaley, D.P.1
Sydes, M.R.2
Langley, R.E.3
Graham, J.D.4
Huddart, R.A.5
Syndikus, I.6
Matthews, J.H.L.7
Scrase, C.D.8
Jose, C.C.9
Logue, J.10
Stephens, R.J.11
-
40
-
-
19944431984
-
Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: The combined experience of nine institutions in patients treated in 1994 and 1995
-
DOI 10.1016/j.ijrobp.2004.05.018, PII S036030160400817X
-
Kupelian P., Kuban D., Thames H., Levy L., Horwitz E., Martinez A., Michalski J., Pisansky T., Sandler H., Shipley W., Zelefsky M., Zietman A., Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995. International Journal of Radiation, Oncology, Biology Physics 2005 61 2 415 419 2-s2.0-19944431984 10.1016/j.ijrobp.2004.05.018 (Pubitemid 40164435)
-
(2005)
International Journal of Radiation Oncology Biology Physics
, vol.61
, Issue.2
, pp. 415-419
-
-
Kupelian, P.1
Kuban, D.2
Thames, H.3
Levy, L.4
Horwitz, E.5
Martinez, A.6
Michalski, J.7
Pisansky, T.8
Sandler, H.9
Shipley, W.10
Zelefsky, M.11
Zietman, A.12
-
41
-
-
0036680314
-
Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial
-
DOI 10.1016/S0360-3016(02)02829-8, PII S0360301602028298
-
Pollack A., Zagars G. K., Starkschall G., Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. International Journal of Radiation, Oncology, Biology Physics 2002 53 5 1097 1105 10.1016/S0360-3016(02)02829-8 (Pubitemid 34787842)
-
(2002)
International Journal of Radiation Oncology Biology Physics
, vol.53
, Issue.5
, pp. 1097-1105
-
-
Pollack, A.1
Zagars, G.K.2
Starkschall, G.3
Antolak, J.A.4
Lee J.Jack5
Huang, E.6
Von Eschenbach, A.C.7
Kuban, D.A.8
Rosen, I.9
-
42
-
-
33646462895
-
Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy
-
DOI 10.1200/JCO.2005.05.2530
-
Peeters S. T., Heemsbergen W. D., Koper P. C. M., van Putten W. L. J., Slot A., Dielwart M. F. H., Bonfrer J. M. G., Incrocci L., Lebesque J. V., Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. Journal of Clinical Oncology 2006 24 13 1990 1996 2-s2.0-33646462895 10.1200/JCO.2005.05.2530 (Pubitemid 46622106)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.13
, pp. 1990-1996
-
-
Peeters, S.T.H.1
Heemsbergen, W.D.2
Koper, P.C.M.3
Van Putten, W.L.J.4
Slot, A.5
Dielwart, M.F.H.6
Bonfrer, J.M.G.7
Incrocci, L.8
Lebesque, J.V.9
-
43
-
-
45449093563
-
Long-term results of conformal radiotherapy for prostate cancer: Impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes
-
2-s2.0-45449093563 10.1016/j.ijrobp.2007.11.066
-
Zelefsky M. J., Yamada Y., Fuks Z., Zhang Z., Hunt M., Cahlon O., Park J., Shippy A., Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. International Journal of Radiation, Oncology, Biology Physics 2008 71 4 1028 1033 2-s2.0-45449093563 10.1016/j.ijrobp.2007. 11.066
-
(2008)
International Journal of Radiation, Oncology, Biology Physics
, vol.71
, Issue.4
, pp. 1028-1033
-
-
Zelefsky, M.J.1
Yamada, Y.2
Fuks, Z.3
Zhang, Z.4
Hunt, M.5
Cahlon, O.6
Park, J.7
Shippy, A.8
-
44
-
-
77953961599
-
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer
-
10.1016/j.ijrobp.2009.07.1691
-
Arcangeli G., Saracino B., Gomellini S., A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer. International Journal of Radiation, Oncology, Biology Physics 2010 78 1 11 18 10.1016/j.ijrobp.2009.07.1691
-
(2010)
International Journal of Radiation, Oncology, Biology Physics
, vol.78
, Issue.1
, pp. 11-18
-
-
Arcangeli, G.1
Saracino, B.2
Gomellini, S.3
-
45
-
-
79951953933
-
Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer
-
2-s2.0-79951953933 10.1016/j.ijrobp.2009.12.045
-
Arcangeli G., Fowler J., Gomellini S., Arcangeli S., Saracino B., Petrongari M. G., Benassi M., Strigari L., Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer. International Journal of Radiation, Oncology, Biology Physics 2011 79 4 1013 1021 2-s2.0-79951953933 10.1016/j.ijrobp.2009.12.045
-
(2011)
International Journal of Radiation, Oncology, Biology Physics
, vol.79
, Issue.4
, pp. 1013-1021
-
-
Arcangeli, G.1
Fowler, J.2
Gomellini, S.3
Arcangeli, S.4
Saracino, B.5
Petrongari, M.G.6
Benassi, M.7
Strigari, L.8
-
46
-
-
84869144788
-
Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer
-
2-s2.0-84859929470 10.1016/j.ijrobp.2012.02.049
-
Arcangeli S., Strigari L., Gomellini S., Saracino B., Petrongari M. G., Pinnarò P., Pinzi V., Arcangeli G., Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer. International Journal of Radiation Oncology, Biology, Physics 2012 84 5 1172 1178 2-s2.0-84859929470 10.1016/j.ijrobp.2012.02.049
-
(2012)
International Journal of Radiation Oncology, Biology, Physics
, vol.84
, Issue.5
, pp. 1172-1178
-
-
Arcangeli, S.1
Strigari, L.2
Gomellini, S.3
Saracino, B.4
Petrongari, M.G.5
Pinnarò, P.6
Pinzi, V.7
Arcangeli, G.8
-
47
-
-
84855302012
-
Preliminary report of a randomized dose escalation trial for prostate cancer using hypofractionation
-
10.1016/j.ijrobp.2010.07.170
-
Kuban D. A., Nogueras-Gonzalez G. M., Hamblin L., Preliminary report of a randomized dose escalation trial for prostate cancer using hypofractionation. International Journal of Radiation Oncology, Biology, Physics 2010 78 3, supplement S58 S59 10.1016/j.ijrobp.2010.07.170
-
(2010)
International Journal of Radiation Oncology, Biology, Physics
, vol.78
, Issue.3 SUPPL.
-
-
Kuban, D.A.1
Nogueras-Gonzalez, G.M.2
Hamblin, L.3
-
48
-
-
84891606493
-
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer
-
10.1200/JCO.2013.51.1972
-
Pollack A., Walker G., Horwitz E. M., Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. Journal of Clinical Oncology 2013 31 31 3860 3868 10.1200/JCO.2013.51.1972
-
(2013)
Journal of Clinical Oncology
, vol.31
, Issue.31
, pp. 3860-3868
-
-
Pollack, A.1
Walker, G.2
Horwitz, E.M.3
-
49
-
-
34547431049
-
Hypofractionated Intensity-Modulated Radiotherapy (70 Gy at 2.5 Gy Per Fraction) for Localized Prostate Cancer: Cleveland Clinic Experience
-
DOI 10.1016/j.ijrobp.2007.01.067, PII S0360301607005354
-
Kupelian P. A., Willoughby T. R., Reddy C. A., Klein E. A., Mahadevan A., Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: cleveland clinic experience. International Journal of Radiation, Oncology, Biology Physics 2007 68 5 1424 1430 2-s2.0-34547431049 10.1016/j.ijrobp.2007.01.067 (Pubitemid 47176809)
-
(2007)
International Journal of Radiation Oncology Biology Physics
, vol.68
, Issue.5
, pp. 1424-1430
-
-
Kupelian, P.A.1
Willoughby, T.R.2
Reddy, C.A.3
Klein, E.A.4
Mahadevan, A.5
-
50
-
-
84855336943
-
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: Preliminary safety results from the CHHiP randomised controlled trial
-
2-s2.0-84855336943 10.1016/S1470-2045(11)70293-5
-
Dearnaley D., Syndikus I., Sumo G., Bidmead M., Bloomfield D., Clark C., Gao A., Hassan S., Horwich A., Huddart R., Khoo V., Kirkbride P., Mayles H., Mayles P., Naismith O., Parker C., Patterson H., Russell M., Scrase C., South C., Staffurth J., Hall E., Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial. The Lancet Oncology 2012 13 1 43 54 2-s2.0-84855336943 10.1016/S1470-2045(11)70293-5
-
(2012)
The Lancet Oncology
, vol.13
, Issue.1
, pp. 43-54
-
-
Dearnaley, D.1
Syndikus, I.2
Sumo, G.3
Bidmead, M.4
Bloomfield, D.5
Clark, C.6
Gao, A.7
Hassan, S.8
Horwich, A.9
Huddart, R.10
Khoo, V.11
Kirkbride, P.12
Mayles, H.13
Mayles, P.14
Naismith, O.15
Parker, C.16
Patterson, H.17
Russell, M.18
Scrase, C.19
South, C.20
Staffurth, J.21
Hall, E.22
more..
-
51
-
-
33747176013
-
High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer
-
DOI 10.1016/j.radonc.2006.06.011, PII S0167814006002532
-
Yoshioka Y., Konishi K., Oh R.-J., Sumida I., Yamazaki H., Nakamura S., Nishimura K., Nonomura N., Okuyama A., Inoue T., High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer. Radiotherapy & Oncology 2006 80 1 62 68 2-s2.0-33747176013 10.1016/j.radonc.2006.06.011 (Pubitemid 44226435)
-
(2006)
Radiotherapy and Oncology
, vol.80
, Issue.1
, pp. 62-68
-
-
Yoshioka, Y.1
Konishi, K.2
Oh, R.-J.3
Sumida, I.4
Yamazaki, H.5
Nakamura, S.6
Nishimura, K.7
Nonomura, N.8
Okuyama, A.9
Inoue, T.10
-
52
-
-
79955571563
-
Monotherapeutic high-dose-rate brachytherapy for prostate cancer: Five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions
-
2-s2.0-79955571563 10.1016/j.ijrobp.2010.02.013
-
Yoshioka Y., Konishi K., Sumida I., Takahashi Y., Isohashi F., Ogata T., Koizumi M., Yamazaki H., Nonomura N., Okuyama A., Inoue T., Monotherapeutic high-dose-rate brachytherapy for prostate cancer: five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions. International Journal of Radiation, Oncology, Biology Physics 2011 80 2 469 475 2-s2.0-79955571563 10.1016/j.ijrobp.2010.02.013
-
(2011)
International Journal of Radiation, Oncology, Biology Physics
, vol.80
, Issue.2
, pp. 469-475
-
-
Yoshioka, Y.1
Konishi, K.2
Sumida, I.3
Takahashi, Y.4
Isohashi, F.5
Ogata, T.6
Koizumi, M.7
Yamazaki, H.8
Nonomura, N.9
Okuyama, A.10
Inoue, T.11
-
53
-
-
70349369485
-
High dose rate monotherapy for prostate cancer
-
supplement 1
-
Schour L., Demanes D. J., Altieri G. A., Brandt D., Barnaba M., Skoolisariyaporn P., High dose rate monotherapy for prostate cancer. International Journal of Radiation, Oncology, Biology Physics 2005 63 supplement 1 S315
-
(2005)
International Journal of Radiation, Oncology, Biology Physics
, vol.63
-
-
Schour, L.1
Demanes, D.J.2
Altieri, G.A.3
Brandt, D.4
Barnaba, M.5
Skoolisariyaporn, P.6
-
54
-
-
81855166655
-
High-dose-rate monotherapy: Safe and effective brachytherapy for patients with localized prostate cancer
-
2-s2.0-81855166655 10.1016/j.ijrobp.2010.10.015
-
Demanes D. J., Martinez A. A., Ghilezan M., Hill D. R., Schour L., Brandt D., Gustafson G., High-dose-rate monotherapy: safe and effective brachytherapy for patients with localized prostate cancer. International Journal of Radiation, Oncology, Biology Physics 2011 81 5 1286 1292 2-s2.0-81855166655 10.1016/j.ijrobp.2010.10.015
-
(2011)
International Journal of Radiation, Oncology, Biology Physics
, vol.81
, Issue.5
, pp. 1286-1292
-
-
Demanes, D.J.1
Martinez, A.A.2
Ghilezan, M.3
Hill, D.R.4
Schour, L.5
Brandt, D.6
Gustafson, G.7
-
55
-
-
51449100864
-
A phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer
-
2-s2.0-51449100864 10.1016/j.ijrobp.2007.12.026
-
Corner C., Rojas A. M., Bryant L., Ostler P., Hoskin P., A phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer. International Journal of Radiation, Oncology, Biology Physics 2008 72 2 441 446 2-s2.0-51449100864 10.1016/j.ijrobp.2007.12. 026
-
(2008)
International Journal of Radiation, Oncology, Biology Physics
, vol.72
, Issue.2
, pp. 441-446
-
-
Corner, C.1
Rojas, A.M.2
Bryant, L.3
Ostler, P.4
Hoskin, P.5
-
56
-
-
84873994847
-
Stereotactic body radiation therapy for prostate cancer: Is the technology ready to be the standard of care?
-
10.1016/j.ctrv.2012.10.003
-
Zaorsky N. G., Studenski M. T., Dicker A. P., Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care? Cancer Treatment Reviews 2013 39 3 212 218 10.1016/j.ctrv.2012.10.003
-
(2013)
Cancer Treatment Reviews
, vol.39
, Issue.3
, pp. 212-218
-
-
Zaorsky, N.G.1
Studenski, M.T.2
Dicker, A.P.3
-
57
-
-
33847248003
-
Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results
-
2-s2.0-33847248003 10.1016/j.ijrobp.2006.10.050
-
Madsen B. L., Hsi R. A., Pham H. T., Fowler J. F., Esagui L., Corman J., Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. International Journal of Radiation, Oncology, Biology Physics 2007 67 4 1099 1105 2-s2.0-33847248003 10.1016/j.ijrobp.2006.10.050
-
(2007)
International Journal of Radiation, Oncology, Biology Physics
, vol.67
, Issue.4
, pp. 1099-1105
-
-
Madsen, B.L.1
Hsi, R.A.2
Pham, H.T.3
Fowler, J.F.4
Esagui, L.5
Corman, J.6
-
58
-
-
55149089265
-
Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localized prostate cancer: Early results of pHART3
-
2-s2.0-55149089265 10.1016/j.clon.2008.08.006
-
Tang C. I., Loblaw D. A., Cheung P., Holden L., Morton G., Basran P. S., Tirona R., Cardoso M., Pang G., Gardner S., Cesta A., Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localized prostate cancer: early results of pHART3. Clinical Oncology 2008 20 10 729 737 2-s2.0-55149089265 10.1016/j.clon.2008.08.006
-
(2008)
Clinical Oncology
, vol.20
, Issue.10
, pp. 729-737
-
-
Tang, C.I.1
Loblaw, D.A.2
Cheung, P.3
Holden, L.4
Morton, G.5
Basran, P.S.6
Tirona, R.7
Cardoso, M.8
Pang, G.9
Gardner, S.10
Cesta, A.11
-
59
-
-
84901805096
-
-
Genitourinary Cancers Symposium 2010 Orlando, Fla, USA
-
Quon H., Cheung P., Cesta A., Phase II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localized prostate cancer: toxicity results of pHART3. Genitourinary Cancers Symposium 2010 Orlando, Fla, USA
-
Phase II Study of A Five-fraction Hypofractionated Accelerated Radiotherapy Treatment for Low-risk Localized Prostate Cancer: Toxicity Results of pHART3
-
-
Quon, H.1
Cheung, P.2
Cesta, A.3
-
60
-
-
84873996862
-
Stereotactic body radiation therapy for low-, intermediate- and high-risk prostate cancer: Disease control and quality of life
-
Katz A. J., Santoro M., DiBlasio F., Stereotactic body radiation therapy for low-, intermediate- and high-risk prostate cancer: disease control and quality of life. International Journal of Radiation, Oncology, Biology Physics 2011 81 2, supplement S100
-
(2011)
International Journal of Radiation, Oncology, Biology Physics
, vol.81
, Issue.2 SUPPL.
-
-
Katz, A.J.1
Santoro, M.2
Diblasio, F.3
-
61
-
-
78650343612
-
Stereotactic body radiotherapy as boost for organ-confined prostate cancer
-
2-s2.0-78650343612
-
Katz A. J., Santoro M., Ashley R., Diblasio F., Witten M., Stereotactic body radiotherapy as boost for organ-confined prostate cancer. Technology in Cancer Research and Treatment 2010 9 6 575 582 2-s2.0-78650343612
-
(2010)
Technology in Cancer Research and Treatment
, vol.9
, Issue.6
, pp. 575-582
-
-
Katz, A.J.1
Santoro, M.2
Ashley, R.3
Diblasio, F.4
Witten, M.5
-
62
-
-
78650982500
-
Stereotactic body radiotherapy for low-risk prostate cancer: Five-year outcomes
-
2-s2.0-78650982500 10.1186/1748-717X-6-3
-
Freeman D. E., King C. R., Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes. Radiation Oncology 2011 6 1, article 3 2-s2.0-78650982500 10.1186/1748-717X-6-3
-
(2011)
Radiation Oncology
, vol.6
, Issue.1
-
-
Freeman, D.E.1
King, C.R.2
-
63
-
-
84855825726
-
Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer
-
2-s2.0-84855825726 10.1016/j.ijrobp.2010.11.054
-
King C. R., Brooks J. D., Gill H., Presti J. C. Jr., Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer. International Journal of Radiation, Oncology, Biology Physics 2012 82 2 877 882 2-s2.0-84855825726 10.1016/j.ijrobp.2010.11.054
-
(2012)
International Journal of Radiation, Oncology, Biology Physics
, vol.82
, Issue.2
, pp. 877-882
-
-
King, C.R.1
Brooks, J.D.2
Gill, H.3
Presti, Jr.J.C.4
-
64
-
-
79951642431
-
Acute toxicity after cyberknife-delivered hypofractionated radiotherapy for treatment of prostate cancer
-
2-s2.0-79951642431 10.1097/COC.0b013e3181c4c7c4
-
Townsend N. C., Huth B. J., Ding W., Garber B., Mooreville M., Arrigo S., Lamond J., Brady L. W., Acute toxicity after cyberknife-delivered hypofractionated radiotherapy for treatment of prostate cancer. American Journal of Clinical Oncology 2011 34 1 6 10 2-s2.0-79951642431 10.1097/COC. 0b013e3181c4c7c4
-
(2011)
American Journal of Clinical Oncology
, vol.34
, Issue.1
, pp. 6-10
-
-
Townsend, N.C.1
Huth, B.J.2
Ding, W.3
Garber, B.4
Mooreville, M.5
Arrigo, S.6
Lamond, J.7
Brady, L.W.8
|